Odd Lots cover image

The Booming Business of Chinese Peptides

Odd Lots

00:00

Peptide Armageddon and Regulatory Actions

Zak recounts the 2023 'peptide Armageddon' ban list and the FDA's cited immune-response concerns affecting compounding.

Play episode from 52:02
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app